Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns
Eur Respir J
.
2016 Nov;48(5):1523-1524.
doi: 10.1183/13993003.01283-2016.
Authors
Leticia Kawano-Dourado
1
2
,
Fernando Zampieri
3
4
,
Alexandre Biasi Cavalcanti
3
,
Lucas Petri Damiani
3
,
Ronaldo Adib Kairalla
2
Affiliations
1
Research Institute - Heart Hospital (Hospital do Coração - HCor), São Paulo, Brazil ldourado@hcor.com.br.
2
Interstitial Lung Disease Unit, Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School, São Paulo, Brazil.
3
Research Institute - Heart Hospital (Hospital do Coração - HCor), São Paulo, Brazil.
4
Intensive Care Unit, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
PMID:
27799398
DOI:
10.1183/13993003.01283-2016
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants*
Humans
Idiopathic Pulmonary Fibrosis*
Pulmonary Fibrosis
Substances
Anticoagulants